Highlights
LSE: VAL       VALIRX PLC ORD 0.1P
Last Price Today's Change   Day's Range   Trading Volume
7.25   0.00 (0.00%)  7.12 - 7.50  287,915

Overview

 
Avg Volume (4 weeks):616,600
4 Weeks Range:6.81 - 9.463
4 Weeks Price Volatility (%):
16.58%
52 Weeks Range:0.03 - 22.90
52 Weeks Price Volatility (%):
31.57%
Average Price Target: 1.66
Price Target Upside/Downside: -5.59

Headlines



No recent Headlines for this stock.


Business Background

ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It operates in two business segments: drug development and the sale of self-test drug kits. Its product pipeline includes VAL101, VAL201, VAL401 and Nav3. VAL201 is an anti-cancer therapeutic drug, which is in clinical trials for the treatment of prostate cancer and other indications of hormone induced unregulated growth including endometriosis. VAL401 is the reformulation of a generic drug for treatment of a chronic non-oncology disease in an oral capsule. VAL101 is a therapeutic based on its Gene Inactivation by chromatin engineering (GeneICE) platform. NAV3 Cancer Screening Test enables the detection of cancer cells in tissue samples. It operates through divisional companies, including ValiPharma, ValiFinn and ValiSeek.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2789  1703  900  2571 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 WINZL 67.12-0.96 
 IPOST 390.75-4.60 
 BOU 0.024+0.001 
 ICON 0.012+0.001 
 EQT 0.45+0.03 
 TRAF 0.24+0.01 
 UJO 0.245-0.01 
 LLOY 30.385+0.28 
 INTU 1.776-2.134 
 VAST 0.233-0.002 
Partners & Brokers